Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome Prophylaxis in HSCT
NCT00326157Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal amphotericin b in invasive fungal infection (IFI), sponsored by Gilead Sciences. Started Jun 2006; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00326157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326157.